Results 151 to 160 of about 74,737 (254)

Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence?

open access: yesLancet Neurology, 2020
Huang-ning Zhao   +4 more
semanticscholar   +1 more source

Perioperative Nivolumab in Resectable Non‐Small Cell Lung Cancer: A Subanalysis of Japanese Patients From CheckMate 77T

open access: yesCancer Science, Volume 117, Issue 3, Page 759-768, March 2026.
ABSTRACT In the randomized phase III CheckMate 77T study, perioperative nivolumab showed statistically significant and clinically meaningful improvement in event‐free survival (EFS) vs. placebo in patients with resectable, non‐metastatic non‐small cell lung cancer (NSCLC).
Fumihiro Tanaka   +17 more
wiley   +1 more source

Síndrome de Guillain-Barré posterior a infección por Varicela-Zoster

open access: yesKasmera, 2003
: Guillain-Barre Syndrome is the most common cause of acute polyradiculoneuropathology. It is an immunological illness, predominantly motor proximal, demyelining and inflammatory, and triggered by a viral or bacterial infectious process, surgery ...
Hernández Pernía Armando   +4 more
doaj  

Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

open access: yesThe Lancet, 2016
Van-Mai Cao-Lormeau   +24 more
semanticscholar   +1 more source

Acquired Multiple Acyl‐Coenzyme A Dehydrogenase Deficiency Associated With Sertraline in Sweden—A Nationwide Population‐Based Study

open access: yesEuropean Journal of Neurology, Volume 33, Issue 3, March 2026.
Multiple acyl‐coenzyme A dehydrogenase deficiency‐like disease has recently been described as a rare adverse effect of sertraline. We performed a nationwide population‐based retrospective study in Sweden (2014–2024) including 40 patients, corresponding to an incidence of 1.24 per 100,000 treated individuals per year.
Sofie Sunebo   +9 more
wiley   +1 more source

Oncologic Emergencies: Immune-Based Cancer Therapies and Complications [PDF]

open access: yes, 2020
Cancer therapies have undergone several recent advancements. Current cancer treatments include immune-based therapies comprised of checkpoint inhibitors, and adoptive immunotherapy; each treatment has the potential for complications that differ from ...
Brém, Elizabeth   +2 more
core  

Multiple Mononeuropathy Secondary to Parvovirus B19 Infection: A Case Series

open access: yesEuropean Journal of Neurology, Volume 33, Issue 3, March 2026.
Parvovirus B19 infection can cause multiple mononeuropathy in young and immunocompetent patients, predominantly affecting sensory nerves, with frequent involvement of the median, fibular, and ulnar nerves, as well as occasional cranial nerve impairment.
Julian Theuriet   +32 more
wiley   +1 more source

Neuroepidemiology [PDF]

open access: yes
Population incidence of Guillain-Barr\ue9 syndrome (GBS) is required to assess changes in GBS epidemiology, but published estimates of GBS incidence vary greatly depending on case ascertainment, definitions, and sample size.

core  

Clinical and Economic Implications of Immunoglobulin Use Under Restrictive Conditions in Adult Patients With Neurological Diseases and Immunodeficiencies in Spain

open access: yesEuropean Journal of Neurology, Volume 33, Issue 3, March 2026.
This study analyzes nationwide hospitalization data from Spain to evaluate the clinical and economic impact of restrictive immunoglobulin access in neurological disorders and immunodeficiencies. Using ICD‐10–coded admissions from 2019 and 2022, changes in clinical outcomes and resource use were assessed.
Luis Querol   +5 more
wiley   +1 more source

Case Report: Exostosin 1-associated membranous nephropathy and Guillain-Barré syndrome: a common autoimmune etiology?

open access: yesFrontiers in Nephrology
Membranous nephropathy is one of the most common causes of nephrotic syndrome in adults and is caused by the deposition of immune complexes in the subepithelial space of the glomerular basement membranes.
Mariana León-Póo   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy